X0306 4/A 2022-01-29 2022-01-31 0000004962 AMERICAN EXPRESS CO AXP 0001753557 Marrs Anna 200 VESEY STREET, AMERICAN EXPRESS TOWER NEW YORK NY 10285-5001 1 Group Pres., GCS and CFR Common Stock 2022-01-29 4 A 0 30507 0 A 36482 D Common Stock 2022-01-29 4 F 0 17106 177.06 D 19376 D Common Stock 2022-01-31 4 M 0 32948 100.96 A 52324 D Common Stock 2022-01-31 4 S 0 29982 177.1384 D 22342 D Common Stock 2022-02-04 4 S 0 6700 184.5518 D 15642 D Employee Stock Option (Right to Buy) 100.96 2022-01-29 4 A 0 32948 0 A 2022-01-29 2029-01-29 Common Stock 32948 32948 D Employee Stock Option (Right to Buy) 100.96 2022-01-31 4 M 0 32948 0 D 2022-01-29 2029-01-29 Common Stock 32948 0 D Represents shares acquired pursuant to vesting of Restricted Stock Units that were granted to the reporting person in January 2019 and have vested based on the Company's 2019-21 average return on equity performance. The reported disposition represents the surrender of shares to satisfy tax obligations arising from the vesting of Restricted Stock Units. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.0100 to $177.3350. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. This amount reflect 2,966 additional shares that had been previously incorrectly classified as a derivative security (stock option) under Table II. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $184.5392 to $184.6100. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. The reported acquisition represents the vesting of Stock Options that were granted to the reported person on 1/29/2019. These options became exercisable on 1/29/2022 based on the Company's positive cumulative net income over the three year performance period. The original Form 4 and the amended Form 4, filed on February 1, 2022 and February 2, 2022, respectively, had each incorrectly classified 2,966 shares of common stock as derivative securities (stock options) on Table II. The stock options were exercised and they are now properly reflected in the reporting person's common stock balance. /s/ Kristina V. Fink, attorney-in-fact 2022-02-07